The biocides sector post Brexit: What firms should expect when the transition period ends
November 27, 2020
With the end of the Brexit transition period in sight, biocide manufacturers will be among the many businesses wondering what comes next. While the future is still uncertain, details of some of the changes to regulatory processes are now becoming clearer.
Sagentia Regulatory’s, formerly TSG Consulting’s, paper addresses some of the concerns United Kingdom (UK) and European Union (EU) businesses are likely to have as they prepare for the changes that lie ahead. In it, our regulatory experts cover amendments to Article 95, how active substance and biocidal product authorisation applications will be handled, what data sharing will look like, what’s next for Northern Ireland (NI), and where all of this leaves biocide firms trading in the UK.
Read more of our advisories
June 15, 2026
California’s pesticide-treated seed proposal and the emerging national framework
June 11, 2026
Health Canada Biocides Emerging Viral Pathogen policy is triggered for ebola disease
May 19, 2026
Regulatory considerations for hantavirus claims on antimicrobial and rodent control products